Sandoz has introduced clobetasol propionate shampoo 0.05%, indicated for the treatment of moderate to severe scalp psoriasis.


Sandoz, clobetasol propionate shampoo, Clobex, authorized generic, Galderma, psoriasis, Clobex Shampoo, pharmaceutical, generic drug maker




































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Sandoz rolls out shampoo for psoriasis

January 6th, 2012

PRINCETON, N.J. – Sandoz has introduced clobetasol propionate shampoo 0.05%, indicated for the treatment of moderate to severe scalp psoriasis.

The generic drug maker, a division of Novartis, said this week that it will market clobetasol propionate shampoo 0.05% in four-fluid-ounce (118 ml) bottles.

According to Sandoz, the product is an authorized generic version of Galderma's Clobex Shampoo 0.05% in the United States.

U.S. sales for branded and generic versions of clobetasol propionate shampoo 0.05% were about $54.9 million for the 12 months ended in October 2011, according to IMS Health figures reported by Sandoz.

The pharmaceutical company added that psoriasis is a common skin condition, affecting up to 7.5 million Americans.

 

Advertisement